The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 10, 2020

Filed:

Jun. 03, 2016
Applicant:

Hema-quebec, Saint-Laurent, CA;

Inventors:

Josée Laganière, Quebec, CA;

Nellie Dumont, Quebec, CA;

Assignee:

HEMA-QUEBEC, Saint-Laurent, CA;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/15 (2015.01); A61K 35/28 (2015.01); A61K 35/19 (2015.01); C12N 5/078 (2010.01); C12N 5/0789 (2010.01);
U.S. Cl.
CPC ...
A61K 35/15 (2013.01); A61K 35/19 (2013.01); A61K 35/28 (2013.01); C12N 5/0644 (2013.01); C12N 5/0647 (2013.01); A61K 2300/00 (2013.01); C12N 2500/36 (2013.01); C12N 2501/125 (2013.01); C12N 2501/14 (2013.01); C12N 2501/145 (2013.01); C12N 2501/2306 (2013.01); C12N 2501/2309 (2013.01); C12N 2501/26 (2013.01); C12N 2501/998 (2013.01); C12N 2501/999 (2013.01); C12N 2523/00 (2013.01);
Abstract

The present description relates to in vitro methods for culturing hematopoietic stem cells (HSCs) under mild hyperthermia conditions (e.g., between 38° C. and 40° C.) in the presence of a pyrimidoindole derivative agonist of hematopoietic stem cell expansion. The combined use of mild hyperthermia and the pyrimidoindole derivative act synergistically to promote expansion of CD34+ HSCs and/or differentiation into progenitor cells (e.g., megakaryocytic progenitors). The present description also relates to in vitro expanded cell populations of HSCs and/or progenitors, as well as uses thereof in therapy (e.g., transplantation).


Find Patent Forward Citations

Loading…